"The brain...spoils and rusts". Certainly a striking image, but a dark one. Its rather like being hit with a truck when you read it as early in the AM as I am. I think I was actually struck speechless for a moment, especially after all the posts yesterday re: cognitive impairment vs. dementia. Poetic license or do you feel that damaged by the disease? Carole H. --- William Harshaw <[log in to unmask]> wrote: > Reflections on Therapy > for > Parkinson's Disease: > Medication and Neurosurgery > by > Bill Harshaw > > Parkinson's Disease is associated with free radicals > which in turn are > associated with the deposition of iron. The human > brain is encased in fat. > For a person with Parkinson's, the brain, which is > the source of the highest > creativity and reasoning, spoils and rusts > > The two procedures I had - the pallidotomy in 1993 > and deep brain > stimulation the following year - are much in the > news as Parkinson's > patients search out possible ways to mitigate their > symptoms and improve the > quality of their lives. Media accounts of these > procedures focus on the > successes, sometimes spectacular, and give less > coverage to the patients > whose lives have not increased in quality. > > Neurosurgery as a therapy for Parkinson's disease > continues to be both > experimental and controversial. Pallidotomy, > thalamotomy, deep brain > stimulation and foetal transplants haven't yet > reached the status of bypass > surgery for cardiac patients - the gold standard. > But it is useful to > remember that they are all based on what the noted > American physician Lewis > Thomas calls ‘halfway technologies'.He does not use > this term derisively, > but to point out that they do not represent a cure, > only better symptom > management. > > Foetal transplant surgery is to the doctors an > extension of the current > ‘gold standard' of treatment, ‘dopamine replacement > therapy', as represented > by the L-dopa based medications. However, it has a > number of ethical and > moral hurdles to clear before becoming acceptable > to society generally. > The other procedures fall into the general category > of what surgeons do > best: "if its broke, fix it" (with apologies to Bert > Lance). > > To put neurosurgery in the context of the universe > of treatment for > Parkinson's it is important to remember that > pallidotomy and thalamotomy > have been around for fifty years. They were the > therapy of choice for > advanced PWPs.untl the mid 1960s when L-dopa was > discovered to be > efficacious. As L-dopa gained acceptance, its > superiority to all other drug > therapies became apparent. Neurosurgery went into > eclipse, not to have a > renaissance for a quarter century, a period which > saw the development of two > generations of a new type of drug - dopamine > agonists - which increase and > prolong the effectiveness of L-dopa. > A quarter century's use of L-dopa as the medication > of choice demonstrated > its superiority in symptom management; it also > revealed the drug's > shortcomings - dyskinesia and psychiatric > side-effects in advanced patients > who were on high doses being among the more > significant.. In the early > 1990s, technological advances, the miniaturization > of surgical instruments, > a more nuanced and comprehensive understanding of > neuroanatomy, a new era in > neuroimaging and the need to provide some sort of > relief to advanced > patients led to a renewal of interest in > neurosurgery - the old operations > being done more successfully and with greater > precision and the invention of > DBS by Alim Benabid and his colleagues in Grenoble > France. Almost > paralleling the surgical innovation was the > development of a third > generation of agonists which, if they live up to > their press releases, will > provide a meaningful advance on current drug > therapy. The procedures and > the drugs are at the limit of human knowledge. > > Foetal transplantation is considered separately. > As a class of surgery, > it belongs with organ transplants - heart, lungs, > kidney ... the list goes > on. It first showed its face in the late 1970s and > has been developing > quickly since then. At times the pace of progress > seems slow to patients, > but the rate of change of progress has been nothing > short of exponential. > Results of a recent double blind study are every bit > as good as were > expected and parallel the results of other the types > of surgery . > > Comparing the state of therapy for Parkinson's > today to what it was a mere > quarter-century ago, the progress is staggering. > Before L-dopa, the > medications available were a variety of drugs which > were serendipitously > found to be beneficial as therapy. They were really > pretty primitive. Now, > there is L-dopa, three generations of agonists, > neurosurgery and a whole new > array of research projects, any one of which has > the potential to advance > treatment markedly. > > It should be noted that every therapy has its > drawbacks, called side > effects, which range from the trivial to the > serious. Some of these side > effects are major enough to prevent certain patients > from using some > therapies. Indeed, there is a website on the > internet devoted to patient > accounts. > > The implications of these advances on a broad field > of new and newly > adapted drug and surgical therapies is that > physicians will have several > arrows in their quiver when presented with a patient > with symptoms that > previously would have been intractable. The other > aspect is the hope that > these developments engender. > > The American philosopher John Searle noted in a > 1995 article: > > As far as we know the relevant processes take place > at the micro levels of > synapses, neurons and cell assemblies. All our > conscious life is caused by > these lower level processes, but we have only the > foggiest idea of how it > all works. > > The doctors know that lesioning works and that > chronic stimulation works, > yet they do not know how or why. That should give > some cause for pause. > The same comment can be made, to a degree, with > respect to drug therapy. We > don't know why some drugs are more effective than > others. > > Perhaps Parkinson's disease will, in the end, be > found to be not one > condition, but a cluster of conditions with several > common characteristics > and each one having unique properties which set it > apart. The existence of > progressive supra-nuclear palsy and multi-system > atrophy are two cases in > point. That is why it is a very good thing that > there are half a dozen > agonists on the market and three types of surgery - > lesioning, stimulation > and transplant. One agonist or type of surgery may > be more effective than > others in different varieties of the condition. > > Research is also yielding results on discovering > the causes of Parkinson's. > PD is caused by the death of the cells comprising > the substantia nigra which > produce dopamine. It is not known what causes the > cells to die. The > prevalent current hypothesis is the so-called > ‘double hit' theory - which > seems to be the case with other neurodegenerative > conditions as well - an > hereditary or genetic predisposition which can be > hit by an environmental > toxin, thus providing the double hit. The toxin > could be anything from > pesticide and fertilizer to industrial pollutants > and === message truncated === _________________________________________________________ Do You Yahoo!? Get your free @yahoo.com address at http://mail.yahoo.com